Immuflash 20 Solution for Infusion contains L-alanyl-L-glutamine (20 gm) as its active ingredient, a dipeptide composed of alanine and glutamine designed to provide a stable and soluble source of glutamine for intravenous administration. This solution is indicated for patients requiring parenteral nutrition support, particularly in clinical settings where glutamine depletion is a concern, such as critical illness, major surgery, trauma, or burns. Glutamine plays a vital role in nitrogen transport, immune function, and intestinal mucosal integrity, and its supplementation may help reduce infectious complications and support recovery. Immuflash 20 is formulated to be administered via intravenous infusion under medical supervision, ensuring appropriate dosing tailored to individual patient needs. The solution is sterile, non-pyrogenic, and intended for use in hospital settings as part of comprehensive nutritional therapy. Contraindications include known hypersensitivity to L-alanyl-L-glutamine or any component of the formulation. Caution is advised in patients with hepatic or renal impairment, and electrolyte imbalances should be monitored during therapy. Adverse reactions are rare but may include hypersensitivity or infusion-related reactions. Immuflash 20 should be used in accordance with established clinical guidelines and under the supervision of healthcare professionals experienced in parenteral nutrition management.